DXSP DXS International Plc

 
TIDMDXSP 
 
 
   DXS INTERNATIONAL PLC 
 
   (AQSE: DXSP) 
 
   Notice of Investor Presentation 
 
   DXS International plc ("DXS", the "Company"), the digital clinical 
decision support Company, is pleased to announce that David Immelman and 
Steven Bauer will provide a live presentation relating to an overview of 
DXS International with emphasis on ExpertCare, the new Chronic Disease 
Management solution which currently focuses on hypertension, via the 
Investor Meet Company platform on 5th March 2021 at 10:00am. The Company 
will also give an update on its Point-of-Care, CompleteCare and 
MyVytalCare products. 
 
   The presentation is open to all existing and potential shareholders. 
Questions can be submitted pre-event via your Investor Meet Company 
dashboard up until 9am the day before the meeting or at any time during 
the live presentation. Investors can sign up to Investor Meet Company 
for free and add to meet the Company via: 
 
   https://www.globenewswire.com/Tracker?data=8xc_Q2l0aChApdKqXKUihvPo4ArkE7RkXvlNBN1QDqdQOHWBa05dapRl8slgBUFMS4ykfQdk1XDR7q-RIGJOWLuafUjkq8yUH43gDAIxHlHW3M-KRCXj6y4Pl-SQc7-mq9ilFmBfYGyQ14Qx_nj8gR4R6S-jUsksSA8b9vWy6QCj4U8pkVBS-QeaTHkG-9dzCWSyRmMtzPx_VORd1vmA5hf3jyVMfOafWwAqSJSF0cI= 
https://www.investormeetcompany.com/dxs-international-plc/register-investor 
 
 
   Investors who already follow DXS International plc on the Investor Meet 
Company platform will automatically be invited. 
 
   The Directors of DXS International plc accept responsibility for this 
announcement. 
 
   Contacts: 
 
 
 
 
David Immelman (Chief Executive)               01252 719800 
 DXS International plc                david@dxs-systems.com 
https://www.dxs-systems.co.uk 
 
 
 
 
 
 
Corporate Advisor 
City & Merchant 
 David Papworth     020 7101 7676 
 
 
 
 
 
 
Corporate Broker 
Hybridan LLP 
 Claire Louise Noyce   020 3764 2341 
 
 
   Notes to Editors 
 
   About DXS: 
 
   DXS International presents up to date treatment guidelines and 
recommendations, from Clinical Commissioning Groups and other trusted 
NHS sources, to doctors, nurses and pharmacists in their workflow and 
during the patient consultation. This effective clinical decision 
support ultimately translates to improved healthcare outcomes delivered 
more cost effectively and which should significantly contribute towards 
the NHS achieving its projected efficiency savings. 
 
 
 
 

(END) Dow Jones Newswires

February 22, 2021 02:00 ET (07:00 GMT)

DXS (AQSE:DXSP)
Gráfica de Acción Histórica
De May 2024 a Jun 2024

DXS (AQSE:DXSP)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024